Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bioadaptives Inc - SIC # 5499 - MISCELLANEOUS FOOD STORES
Ticker
Exchange
SIC #
Website
Latest Ticker
BDPT
Over the counter
5499
https://www.shopbioadaptives.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bioadaptives Inc
BioAdaptives, Inc. Establishes a Wholesale Division to Expand Marketing Presence in a USD 151.9 Billion Global Dietary Supplement Market
- Dec 8th, 2022 1:00 pm
BioAdaptives, Inc. Introduces PROTEINnMORE, an Advanced, Plant-Based Lean Muscle Supplement for Fitness and Athletic Peak Performance
- Dec 1st, 2022 1:00 pm
As Global Anti-aging Product Annual Sales are Expected to Exceed 44 Billion by 2027, BioAdaptives, Inc. Launches Cell Rejuven, an Advanced, Plant-Based Anti-Aging Supplement With Rejuvenating Effects
- Nov 17th, 2022 1:00 pm
BioAdaptives Launches MindnMemory Nootropic Mental Focus, Clarity, Concentration
- Jul 28th, 2022 11:00 am
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
- Jul 14th, 2022 11:00 am
BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body's Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No "Hangover"
- Jul 7th, 2022 11:00 am
BioAdaptives, Inc. Brings Top Revolutionary Formulas Together in Wellness Introductory Offer
- Jun 29th, 2022 11:00 am
BioAdaptives, Inc. Seeks to Increase Market Share in $1.9 Billion Global Pet Supplements Market With Canine All-In-One Premium Nutraceutical
- Jun 23rd, 2022 11:00 am
BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD
- Jun 9th, 2022 11:00 am
BioAdaptives Sponsors COVID-19 Long Hauler Survey
- Jun 2nd, 2022 11:00 am
BioAdaptives Expands Gadolinium Deposition Disease Survey
- Feb 25th, 2022 3:00 pm
BioAdaptives Announces Initial Investigation Results Pluripain® Improves Symptoms of Gadolinium Deposition Disease
- Feb 24th, 2022 12:00 pm
BioAdaptives Acquires Oxygenated Water Technology Patent and Forms Subsidiary, MORO2, Inc., to Create New Products
- Feb 3rd, 2022 12:00 pm
Scroll